ID   L2G7
AC   CVCL_F1WT
RX   Patent=US7494650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5162.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the HuL2G7 humanized (TAK-701) therapeutic antibody investigated as a potential anti-cancer drug that works by binding to HGF to block the c-Met signaling pathway, which is involved in tumor growth, survival, and metastasis.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   Patent=US7494650;
RA   Kim, Kyung Jin
RA   Su, Yi-Chi
RT   "Monoclonal antibodies to hepatocyte growth factor.";
RL   Patent number US7494650, 24-Feb-2009.
//